Locations:
Search
New reports focus on neuroimaging biomarkers and features of atypical presentations
Findings challenge dogma that microglia are exclusively destructive regardless of location in brain
New review distills insights from studies over the past decade
Updated consensus approach helps clinicians efficiently improve diagnostic accuracy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
As patients age, there’s a case to be made for questioning treatment paradigms
The disease is not a barrier to pregnancy, but risks from disease-modifying therapies must be managed
In search of optimal imaging biomarkers, best methods for long-term follow-up
Pilot study finds both forced- and voluntary-rate cycling effective for symptom management
Risk of new MS activity is small in those older than 55 with stable disease who stop MS therapy
$1.1M award expands follow-up to six years with focus on clinical endpoints
Advertisement
Advertisement